MDLY Fundamental Analysis - Medley Management Inc

Fundamental Rating

Taking everything into account, MDLY scores 1 out of 10 in our fundamental rating. MDLY was compared to 233 industry peers in the Capital Markets industry. Both the profitability and financial health of MDLY have multiple concerns. MDLY is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

MDLY had negative earnings in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-7.49%
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	-14.15%
PM (TTM)	-8.01%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MDLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

MDLY has an Altman-Z score of -3.68. This is a bad value and indicates that MDLY is not financially healthy and even has some risk of bankruptcy.

MDLY has a Debt/Equity ratio of -0.97. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	-0.97
Debt/FCF	N/A
Altman-Z	-3.68

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.

A Quick Ratio of 0.14 indicates that MDLY may have some problems paying its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	0.14
Quick Ratio	0.14

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.00% over the past year.

Looking at the last year, MDLY shows a very negative growth in Revenue. The Revenue has decreased by -31.92% in the last year.

Measured over the past years, MDLY shows a very negative growth in Revenue. The Revenue has been decreasing by -13.18% on average per year.

EPS 1Y (TTM)29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.25%

Revenue 1Y (TTM)-31.92%

Revenue growth 3Y-20.04%

Revenue growth 5Y-13.18%

Sales Q2Q%-20.43%

3.2 Future

The Earnings Per Share is expected to decrease by -3.61% on average over the next years.

Based on estimates for the next years, MDLY will show a very negative growth in Revenue. The Revenue will decrease by -31.10% on average per year.

EPS Next Y0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-11.41%

Revenue Next 2Y-31.1%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

MDLY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDLY. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	-57.79

4.3 Compensation for Growth

MDLY's earnings are expected to decrease with -3.61% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-3.61%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.90%, MDLY is a good candidate for dividend investing.

The stock price of MDLY dropped by -29.50% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.

Compared to an average S&P500 Dividend Yield of 2.38, MDLY pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	11.9%

5.2 History

The dividend of MDLY decreases each year by -34.93%.

MDLY has been paying a dividend for over 5 years, so it has already some track record.

Dividend Growth(5Y)-34.93%

Div Incr YearsN/A

Div Non Decr YearsN/A

5.3 Sustainability

The Dividend Rate of MDLY has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.

DP0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

Medley Management Inc

NYSE:MDLY (7/6/2021, 8:04:00 PM)

5.88

+0.1 (+1.73%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0%

Inst Owner Change0%

Ins Owners403.16%

Ins Owner Change0%

Market Cap3.94M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	11.9%

Yearly Dividend0.7

Dividend Growth(5Y)-34.93%

DP0%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.12
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	-57.79

EPS(TTM)-4.26

EYN/A

EPS(NY)-0.17

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS49.63

BVpS-199.51

TBVpSN/A

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.49%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	-14.15%
PM (TTM)	-8.01%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y0%

ROICexcg growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score0

Asset Turnover0.94

Health

		Industry Rank	Sector Rank
Debt/Equity	-0.97
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.14
Quick Ratio	0.14
Altman-Z	-3.68

F-Score0

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)29%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%81.25%

EPS Next Y0%

EPS Next 2Y-3.61%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.92%

Revenue growth 3Y-20.04%

Revenue growth 5Y-13.18%

Sales Q2Q%-20.43%

Revenue Next Year-11.41%

Revenue Next 2Y-31.1%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A

Medley Management Inc (MDLY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens